Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. - Wikidata - wikimedia - TriplyDB

Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat.

Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat.

http://www.wikidata.org/entity/Q40662503

about

Is Stevia rebaudiana Bertoni a Non Cariogenic Sweetener? A Review Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies.Isosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expression Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials.Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic goto-kakizaki rat.A pharmacological appraisal of medicinal plants with antidiabetic potential Glycemic Effects of Rebaudioside A and Erythritol in People with Glucose Intolerance Potential Roles of Stevia rebaudiana Bertoni in Abrogating Insulin Resistance and Diabetes: A Review.A research on the genotoxicity of stevia in human lymphocytes.Combating Combination of Hypertension and Diabetes in Different Rat Models Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase.Stevioside improves pancreatic beta-cell function during glucotoxicity via regulation of acetyl-CoA carboxylase.Stevioside counteracts the alpha-cell hypersecretion caused by long-term palmitate exposure.Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion.Influence of terpenoids and acarbose on glycosyltransferases produced by strain Leuconostoc mesenteroides URE 13.The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after eight weeks treatment in the Goto-Kakizaki rat.Stevia rebaudiana Bertoni as a source of bioactive compounds: the effect of harvest time, experimental site and crop age on steviol glycoside content and antioxidant properties.Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose.Scientific Opinion on the safety of steviol glycosides for the proposed uses as a food additive Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome.The Dynamic Effects of Isosteviol on Insulin Secretion and Its Inability to Counteract the Impaired β-Cell Function during Gluco-, Lipo-, and Aminoacidotoxicity: Studies In Vitro.Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus.Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 Upregulation.Stevia Nonsweetener Fraction Displays an Insulinotropic Effect Involving Neurotransmission in Pancreatic Islets.Anti diabetic property of aqueous extract of Stevia rebaudiana Bertoni leaves in Streptozotocin-induced diabetes in albino rats.Synthesis and evaluation of 2,3-indolotriterpenoids as new α-glucosidase inhibitors

P2860

Q26771831-68A529C7-60FF-41A9-AF08-9EB6109C8C21 Q26781277-CB6C886F-F8D8-474E-AD18-FFAF0865C5FC Q28481674-266C8CC4-0E9B-4E7E-B5BC-9F1C76E24DA5 Q35184679-208C70FC-0DE2-4BD8-B7A0-93BC39CDB124 Q35440535-FD1EA1ED-0068-4D81-A4C5-8D8C5CEE6422 Q35688751-7EB33B18-92CC-422A-8E79-1203EA564F86 Q35770444-A6FB6088-760F-4773-A7E6-339A2CF789BF Q37198145-DE36280F-6C0A-42E8-AB32-9656DA18BDEB Q38170114-72A35924-AE53-403D-9B4F-4C00A83C348D Q38664429-43C4FEBF-5A9A-4AE4-8843-A3F81532D75E Q38974232-F9AA98BE-C9ED-44B0-8A0B-F170E206BE7D Q40135633-1E70EED5-8482-419D-BFA8-6643D902A8B4 Q40162688-AE6F53EF-C7B3-4C3A-AF4C-CAB6A71E46EF Q40365602-129E28FA-BE41-4A20-97CB-408C9C72DB88 Q40666843-93B45AC2-2236-45E8-AB6A-363F48E868B8 Q40740479-6F55986B-0FC5-4880-A101-9B5F97B4F61A Q42976532-DC210D46-549A-4153-98FF-A06F1D13DE98 Q44793879-E378A3C9-7455-4AA6-B781-311BBD60851F Q47140886-E015F2E2-600B-4C3D-89D6-64B112D1382F Q47148221-C56EEA31-2271-4894-84C8-D19BE04EB495 Q47814091-50FFE964-EF38-4744-A13B-D42177947CDF Q48159452-04322169-3081-4160-BB70-4BA26C4E25EA Q51290734-4E834A01-A1FA-4E52-9367-835957F30E40 Q55052958-2D92D9D4-49B9-4BE0-8C55-BF7C59499D9F Q55345246-92EA5A97-6A53-4770-86CA-827CEB43B483 Q55397511-FEC8F832-6D0E-46EF-A81A-502C3E72AB92 Q59310415-0AA85A1F-F6CE-4D07-91F5-A5DAC9BA8CB3

P2860

Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat.

http://www.wikidata.org/entity/Q40662503

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Antihyperglycemic and blood pr ...... he diabetic Goto-Kakizaki rat.

@en

type

label

Antihyperglycemic and blood pr ...... he diabetic Goto-Kakizaki rat.

@en

prefLabel

Antihyperglycemic and blood pr ...... he diabetic Goto-Kakizaki rat.

@en

P1433

Q40662503-8D1EE1A1-1521-4335-897A-CC9E3C98B892

P1476

Q40662503-AE1B553C-E6D5-4BEF-8062-5DE5742FA145

P2093

Q40662503-0A8E743D-6913-4046-A5ED-BCE52607DDC5

Q40662503-3D737507-2C34-4389-A069-52DBF682A2B4

Q40662503-65E32E94-6B41-4271-B236-EC0BB6AE93CF

Q40662503-78EC66B5-1D74-4D25-9491-025AEAF1B6CD

Q40662503-7C52F994-CDD8-4E38-8153-E70F4255466C

Q40662503-8A43126C-D006-4D8E-986D-A3BBDA544D5A

Q40662503-B07EEF25-C7C3-4035-B6C4-573077EA8ECD

Q40662503-C5BE310E-E12D-4E78-AF57-F9CCB9C4A88F

Q40662503-E23AE7A3-B886-45BC-9587-365CDDD92F44

Q40662503-E9B355B7-E002-4033-8B0A-41BFACA40B3E

P304

Q40662503-172014EB-5A23-43F2-8BC4-F70B5B1E5F7F

P31

Q40662503-5792EFCB-1FC2-462D-81C9-DC04A7972BAC

P356

Q40662503-05168619-5516-4FA8-8D85-F7B437F34A3D

P433

Q40662503-ED2B7207-4A9C-4330-95EC-2D8D68B7E19D

P478

Q40662503-09B4E930-7978-4FF8-B8FC-38F4D40544D2

P577

Q40662503-93EB502C-A62A-43F6-B7C2-F52EDFCED1C5

P5875

Q40662503-7D585B35-B24C-42DE-A8FF-2EA2E85BD7B4

P698

Q40662503-10B047F6-6D77-400A-9C8B-67A48B56B7FE

P356

META.2003.50058

P1433

P1476

Antihyperglycemic and blood pr ...... he diabetic Goto-Kakizaki rat.

@en

P2093

Agger A

http://www.w3.org/2001/XMLSchema#string

Colombo M

http://www.w3.org/2001/XMLSchema#string

Gregersen S

http://www.w3.org/2001/XMLSchema#string

Hermansen K

http://www.w3.org/2001/XMLSchema#string

Jeppesen PB

http://www.w3.org/2001/XMLSchema#string

Jepsen M

http://www.w3.org/2001/XMLSchema#string

Kruhøffer M

http://www.w3.org/2001/XMLSchema#string

Orntoft T

http://www.w3.org/2001/XMLSchema#string

Rolfsen SE

http://www.w3.org/2001/XMLSchema#string

Xiao J

http://www.w3.org/2001/XMLSchema#string

P304

372-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/META.2003.50058

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10847585

http://www.w3.org/2001/XMLSchema#string

P698

12647278

http://www.w3.org/2001/XMLSchema#string